Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06575595
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-16
Brief Title:
Pharmacokinetic PK Characterization of Subcutaneous Tulisokibart MK-7240-010
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Pharmacokinetic Study of Tulisokibart Administered Subcutaneously Via Autoinjector or Syringe in Healthy Adult Participants
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objectives of the study are to characterize the pharmacokinetics PK of a single subcutaneous SC dose of tulisokibart MK-7240 administered via autoinjector AI Treatment A and to characterize the PK of different concentrations of tulisokibart following SC administration of a single dose via vialsyringe Treatments B and C There is no formal hypothesis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None